FORMULATION AND EVALUATION OF DEXLANSOPRAZOLE DELAYED RELEASE CAPSULES

Journal Title: Indian Journal of Research in Pharmacy and Biotechnology - Year 2013, Vol 1, Issue 1

Abstract

The present research work is formulation and evaluation of dexlansoprazole delayed release capsules. Dexlansoprazole is proton pump inhibitor (PPI) used in treatment of gastro esophageal reflux disease (G.E.R.D), Erosive esophagitis (E.E) and acid – related factors. In this research work various polymers like HPMC P55 S, Eudragit L 100 were used as enteric coating polymers were prepared in a fluidized bed coater (FBC). The pre-formulation studies such as solubility and compatability studies were carried out. In the formulation study of dexlansoprazole different formulation (F1 - F10) have been formulated and evaluated for acid resisitance, dissolution profile and release kinetics. The drug percentage release is more when compared with the marketed product. Stability study was done at various storage conditions and months for description, assay, water content, related substances. Mainly research work is to develop a pharmaceutically equivalent low cost quality improved and stable formulation and evaluation of dexlansoprazole delayed release capsules comparable to innovator product.

Authors and Affiliations

Peer Basha Syed, Chakravarthi V,Venkateswarlu B,Koteswararao P, Farooq Ahmed

Keywords

Related Articles

Some H.R. methodology/ techniques for costs reduction in companies to improve profit

It is not easy to compete in the market today. Rising prices, shifting fuel rates, global competition, varying labor rates around the world, and spiraling health insurance costs have made cost control a moving target....

Application of nano materials in pharmacy and agriculture

Nano materials, applications in Pharmacy(Carbon nanotubes, Quantum dots, Dendrimers, Metallic nanoparticles, Polymeric nanoparticles, Liposomes, Polymeric micelles, Polymer drug conjugate and Polyplexes/Lipopolyplexes)...

Sustained release drug delivery system: review

Sustained release dosage forms are designed to release a drug at a predetermined rate by maintaining a constant drug level for a specific period of time with minimum side effects. The basic rationale of sustained relea...

FORMULATION, CHARACTERIZATION AND IN-VITRO DISSOLUTION STUDIES OF DICLOFENAC SODIUM TABLETS THROUGH SOLID DISPERSION USING POLY ETHYLENE GLYCOL

In the present study the formulation of Diclofenac sodium tablet from poly ethylene glycol solid dispersion has been carried to enhance the bioavailability and solubility of the drug, Diclofenac. The post compression s...

Method Development and Validation of Piperacillin and Tazobactum in Pharmaceutical dosage form by using RP-HPLC Method

A simple and selective LC method is described for the determination of Piperacillin and Tazobactum in tablet dosage forms. Chromatographic separation was achieved on a c18 column using mobile phase consisting of a mixt...

Download PDF file
  • EP ID EP33018
  • DOI -
  • Views 413
  • Downloads 0

How To Cite

Peer Basha Syed, Chakravarthi V, Venkateswarlu B, Koteswararao P, Farooq Ahmed (2013). FORMULATION AND EVALUATION OF DEXLANSOPRAZOLE DELAYED RELEASE CAPSULES. Indian Journal of Research in Pharmacy and Biotechnology, 1(1), -. https://europub.co.uk/articles/-A-33018